| __timestamp | BioMarin Pharmaceutical Inc. | Zoetis Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 129764000 | 1717000000 |
| Thursday, January 1, 2015 | 152008000 | 1738000000 |
| Friday, January 1, 2016 | 209620000 | 1666000000 |
| Sunday, January 1, 2017 | 241786000 | 1775000000 |
| Monday, January 1, 2018 | 315264000 | 1911000000 |
| Tuesday, January 1, 2019 | 359466000 | 1992000000 |
| Wednesday, January 1, 2020 | 524272000 | 2057000000 |
| Friday, January 1, 2021 | 470515000 | 2303000000 |
| Saturday, January 1, 2022 | 483669000 | 2454000000 |
| Sunday, January 1, 2023 | 577065000 | 2710000000 |
| Monday, January 1, 2024 | 580235000 | 2719000000 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for investors and stakeholders. This analysis compares the cost of revenue for Zoetis Inc. and BioMarin Pharmaceutical Inc. from 2014 to 2023. Over this period, Zoetis Inc. consistently outpaced BioMarin, with its cost of revenue peaking at approximately $2.71 billion in 2023, a 58% increase from 2014. In contrast, BioMarin's cost of revenue grew by 345%, reaching around $577 million in 2023. This stark difference highlights Zoetis's larger scale and market presence. However, BioMarin's rapid growth rate suggests a dynamic shift in its operational strategy. As the pharmaceutical landscape continues to change, these trends offer valuable insights into each company's financial health and strategic direction.
Cost of Revenue Trends: Merck & Co., Inc. vs BioMarin Pharmaceutical Inc.
Cost of Revenue Comparison: Pfizer Inc. vs BioMarin Pharmaceutical Inc.
Cost of Revenue: Key Insights for Zoetis Inc. and BeiGene, Ltd.
Comparing Cost of Revenue Efficiency: Zoetis Inc. vs Corcept Therapeutics Incorporated
Cost Insights: Breaking Down Zoetis Inc. and Vericel Corporation's Expenses
Zoetis Inc. vs Ligand Pharmaceuticals Incorporated: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Zoetis Inc. vs Travere Therapeutics, Inc.
United Therapeutics Corporation vs BioMarin Pharmaceutical Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: BioMarin Pharmaceutical Inc. vs Sarepta Therapeutics, Inc.
BioMarin Pharmaceutical Inc. vs Catalent, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: BioMarin Pharmaceutical Inc. vs Cytokinetics, Incorporated